NDC 63020-533-30
Iclusig 30 mg/1
ponatinib hydrochloride · TABLET, FILM COATED
Iclusig (ponatinib hydrochloride) is an oral tablet used to treat certain types of blood cancers, including chronic myeloid leukemia and acute lymphoblastic leukemia. It works by blocking specific proteins that help cancer cells grow and divide.
Key Facts
- Brand Name
- Iclusig
- Generic Name
- ponatinib hydrochloride
- NDC Code (Package)
63020-533-30- NDC Code (Product)
63020-533- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 30 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA203469
- Marketing Start
- 04/22/2015
Recall History
No Recall HistoryView Full Drug Page
Iclusig — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.